Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Investigational CRISPR therapy succeeds in patient with drug-resistant E. Coli
The CRISPR therapy, SNIPR001, was administered to the patient who had developed E. Coli following a single-patient emergency IND.
Read Full Article
Pharma Tech
Infinimmune raises $75m with big pharma backing for atopic dermatitis drugs
Infinimmune is targeting first-in-human studies with its longer-lasting monoclonal antibodies in 2027.
Read Full Article
Pharma Tech
Epicrispr, Vaderis secure pivotal study funding for rare disease assets
Epicrispr and Vaderis have secured $90m and $152m, respectively, to take their rare disease drugs to pivotal clinical development.
Read Full Article
Express Pharma
Indiaâs pharma exports rise 6.8% to $8.1 billion in Q1 FY27
Pharmexcil data shows growth across formulations, bulk drugs, vaccines and surgical products, with the US remaining the largest export destination The post Indiaâs pharma exports rise 6.8% to $8.1 billion in Q1 FY27 appeared first on Express Pharma.
Read Full Article
Pharma Tech
Mereo BioPharma and Sentynl Therapeutics sign licensing deal for alvelestat
Mereo BioPharma and Sentynl Therapeutics have signed an option and licence agreement related to the US commercial and worldwide manufacturing rights to alvelestat, a potential oral treatment for AATD-LD.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Aug 12, 2026, 1:19 PM
Zydus' subsidiary inks optional licensing agreement with Mereo BioPharma for rare respiratory drug
The agreement gives Zydusâ subsidiary, Sentynl Therapeutics option to acquire exclusive commercial rights of, âalvelestatâ for the treatment of AATD-LD (a rare genetic respiratory disease) in the US along with global manufacturing rights.
PharmaShots
Aug 12, 2026, 12:30 PM
Elevation Spine Receives FDA Clearance for Saber-XA ALIF System
Shots: Ref: Businesswire |  Image: Elevation Spine |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Elevation Spine Receives FDA Clearance for Saber-XA ALIF System appeared first on PharmaShots.
PharmaShots
Aug 12, 2026, 11:30 AM
Rhythm Pharmaceuticalsâ Imcivree Receives Expanded UK Authorization for Hypothalamic Obesity
Shots: Ref: Globenewswire |  Image: Rhythm |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Rhythm Pharmaceuticalsâ Imcivree Receives Expanded UK Authorization for Hypothalamic Obesity appeared first on PharmaShots.
ET Pharma
Aug 12, 2026, 10:59 AM
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide
The Indianapolis-based drugmaker said the lawsuits target a range of businesses, including compounding pharmacies, medical spas âand online sellers that allegedly marketed retatrutide products to consumers despite the drug remaining under clinical development.
PharmaShots
Aug 12, 2026, 10:30 AM
Belenos Biosciences Reports P-II Trial Results on BEL512 for CRSwNP
Shots: Ref: Businesswire |  Image: Belenos |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Belenos Biosciences Reports P-II Trial Results on BEL512 for CRSwNP appeared first on PharmaShots.
ET Pharma
Aug 12, 2026, 10:24 AM
Glenmark reaches $15.2 million settlement with Humana in US generic drug antitrust case
In an intimation the stock exchange, the Mumbai-based drugmaker said, âit has agreed to enter into a settlement with insurance company, Humana for the total amount of $15.28 million, including interest, payable in two installments.â
News
Latest industry coverage
Google News
Aug 12, 2026, 5:02 PM
Helus Pharma at Canaccord Genuity growth conference: phase iii test looms - Investing.com
Helus Pharma at Canaccord Genuity growth conference: phase iii test looms  Investing.com
Google News
Aug 12, 2026, 4:39 PM
Morgan Xu Highlights Key Trends Shaping China's Biotech Sector at CPIC 2026 - Foley Hoag
Morgan Xu Highlights Key Trends Shaping China's Biotech Sector at CPIC 2026Â Â Foley Hoag
Google News
Aug 12, 2026, 4:30 PM
Perlen Packaging Expands into Pharma Bottles Market - Contract Pharma
Perlen Packaging Expands into Pharma Bottles Market  Contract Pharma
Google News
Aug 12, 2026, 4:15 PM
Again acquires Geno to advance biomanufacturing at scale with AI design - SiliconANGLE
Again acquires Geno to advance biomanufacturing at scale with AI design  SiliconANGLE
Google News
Aug 12, 2026, 4:05 PM
Penny for Your Thoughts: Episode 16 - Pharmaceutical Commerce
Penny for Your Thoughts: Episode 16Â Â Pharmaceutical Commerce
Google News
Aug 12, 2026, 4:02 PM
Biotech Protein, Vitamin Production Now Economical - Mirage News
Biotech Protein, Vitamin Production Now Economical  Mirage News
Google News
Aug 12, 2026, 4:01 PM
WHO unveils global framework for greener pharmaceuticals - BusinessMirror
WHO unveils global framework for greener pharmaceuticals  BusinessMirror
Google News
Aug 12, 2026, 3:49 PM
Intranasal Drug Delivery Devices Market Study Explores Industry Growth Toward $99.11 Billion - EIN News
Intranasal Drug Delivery Devices Market Study Explores Industry Growth Toward $99.11 Billion  EIN News
Google News
Aug 12, 2026, 3:48 PM
Injectable Drug Delivery Devices Market Study Highlights How Industry Demand Is Evolving - EIN News
Injectable Drug Delivery Devices Market Study Highlights How Industry Demand Is Evolving  EIN News
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer